Skip to main content

Day: January 30, 2026

Zaya Younan Enters Renewable Energy with One of California’s Largest Solar + Storage Power Plants

New Project Developed Under Soleil Renewable Energy Designed to Become One of the Top Five Largest Power-Generating Solar Facilities in the State of California,The new project, developed under Soleil Renewable Energy, LLC, is designed to become one of the top five largest power-generating solar facilities in the State of California, reinforcing a long-term commitment to innovation, sustainability, and next-generation technology.Zaya Younan Enters Renewable Energy with One of California’s Largest Solar + Storage Power PlantsAt full capacity, the Soleil facility is projected to generate approximately 1,900–2,000 gigawatt-hours of electricity annually, translating into an estimated $100 million in annual gross revenue.Los Angeles, CA, Jan. 30, 2026 (GLOBE NEWSWIRE) — Visionary entrepreneur and global business leader...

Continue reading

Rapala VMC and Okuma Announce New Distribution Agreement in Australia

Rapala VMC and Okuma Announce New Distribution Agreement in AustraliaRapala VMC and Okuma Announce New Distribution Agreement in AustraliaPRESS RELEASE, January 30, 2026 Rapala VMC Corporation (“Rapala VMC”) is pleased to announce a new distribution agreement with Okuma Fishing Tackle Co Ltd (“Okuma”) in Australia, bringing the globally respected Okuma range into the Rapala Australia product portfolio. The agreement is set to commence on February 1, 2026. The addition of Okuma strengthens Rapala Australia’s overall offering and expands its ability to serve anglers across all fishing situations and environment, from freshwater to saltwater, and from inshore to offshore applications. This agreement marks a strategic expansion of Rapala Australia’s product portfolio, supporting a more complete range across key fishing categories...

Continue reading

Star Bulk Announces Date for the Release of Fourth Quarter Ended December 31, 2025, Results, Conference Call, and Webcast

ATHENS, Greece, Jan. 30, 2026 (GLOBE NEWSWIRE) — Star Bulk Carriers Corp. (the “Company” or “Star Bulk”) (Nasdaq: SBLK), today announced that it will release its results for the fourth quarter ended December 31, 2025, after the market closes in New York on Wednesday, February 25, 2026. Star Bulk’s management team will host a conference call to discuss the Company’s financial results on Thursday, February 26, 2026, at 11:00 a.m. Eastern Time (ET). Conference Call details: Participants should dial into the call 10 minutes before the scheduled time using the following numbers: +1 877 405 1226 (US Toll-Free Dial In) or +1 201 689 7823 (US and Standard International Dial In), or +0 800 756 3429 (UK Toll Free Dial In). Please quote “Star Bulk Carriers” to the operator and/or conference ID 13758436....

Continue reading

Ledyard Financial Group Earns $2.0 Million, or $0.59 Per Diluted Share, in Q4 2025, and $6.0 Million, or $1.81 Per Diluted Share, for the Full Year 2025, Declares Quarterly Cash Dividend of $0.21 Per Share

HANOVER, N.H., Jan. 30, 2026 (GLOBE NEWSWIRE) — Ledyard Financial Group, Inc. . (the “Company”, OTCQX®: LFGP), the holding company for Ledyard National Bank (the “Bank”), today reported quarterly net income per diluted share of $0.59, for the fourth quarter ended December 31, 2025, up 28% from $0.46 in the prior quarter, as core business activity continued to expand. Strong loan growth continued to drive balance sheet expansion, and wealth management revenue increased with growth in AUM. Reflecting the continued success of the company’s strategic investments, net income for the fourth quarter of 2025 was $2.0 million, up 47% over the comparable year-ago period and approaching a quarterly pace of earnings that nears the high points of previous years. For the full year, the Company reported net income of $6.0 million, or $1.81 per...

Continue reading

Independent Proxy Advisory Firm ISS Recommends Shareholders Vote “FOR” Middlefield Banc Corp. Proposed Merger with Farmers National Banc Corp.

Recommendation Highlights Strategic Benefits and Value Creation of Merger The Board of Directors Urges Shareholders to Vote by February 9, 2026, at 11:59 p.m., ET MIDDLEFIELD, Ohio, Jan. 30, 2026 (GLOBE NEWSWIRE) — Middlefield Banc Corp. (NASDAQ: MBCN) today announced that Institutional Shareholder Services, Inc. (“ISS”), an independent proxy advisory firm, has recommended shareholders vote “FOR” all proposals at the Special Meeting of Shareholders to be held virtually on February 10, 2026, including the Company’s proposed merger of Middlefield Banc Corp. (“Middlefield”), the holding company for The Middlefield Banking Company (“Middlefield Bank”), into Farmers National Banc Corp. (“Farmers”) (NASDAQ: FMNB), the holding company for The Farmers National Bank of Canfield (“Farmers National Bank”). ISS is widely recognized as a leading...

Continue reading

Amplia Therapeutics – Quarterly Activities and Cash Flow Reports – December 2025

Melbourne, Australia, Jan. 30, 2026 (GLOBE NEWSWIRE) — Key Highlights from the QuarterACCENT Trial Success: The ACCENT trial, testing narmafotinib with gemcitabine and Abraxane®, continues to demonstrate that narmafotinib is well tolerated by patients whilst enhancing the effects of chemotherapy AMPLICITY Trial Initiation: The Phase 1b/2a AMPLICITY trial has started, combining narmafotinib with FOLFIRINOX chemotherapy, aiming to determine the optimal daily dose. Patient recruitment is ongoing in Melbourne and Sydney with US sites planned to open imminently Regulatory and Commercial Developments: Positive FDA feedback on dose optimization was received; a key patent for narmafotinib was granted; and Amplia successfully uplisted to the US-based OTCQB Venture Market, enhancing its investor reach Preclinical Studies: The second phase...

Continue reading

ALX Oncology Announces Pricing of Underwritten Offering

SOUTH SAN FRANCISCO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced the pricing of an underwritten offering of common stock and pre-funded warrants. ALX Oncology is selling 76,979,112 shares of common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase 18,574,120 shares of common stock in the offering. The shares of common stock are being sold at an offering price of $1.57 per share, the closing price on January 29, 2026, and the pre-funded warrants are being sold at an offering price of $1.569 per pre-funded warrant, which represents the per share offering price for each share of common stock...

Continue reading

IperionX – December 2025 Quarterly Report

CHARLOTTE, N.C., Jan. 30, 2026 (GLOBE NEWSWIRE) — IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to present its quarterly report for the period ending December 31, 2025. Highlights during and subsequent to the end of the quarter include: Commercial operationsCommissioning Complete: Equipment and systems for both titanium powder production and component manufacturing have been fully commissioned at the Titanium Manufacturing Campus in Virginia. Manufacturing Capacity Expansion: Advanced manufacturing capabilities continue to expand. The 100-ton uniaxial press (producing titanium nuts, bolts, and washers) and dry bag cold isostatic press (large titanium fasteners) are now operational. Additionally, a new 300-ton hydraulic press – designed for complex tiered shapes for consumer electronics enclosures or humanoid...

Continue reading

Reliance Global Group Reports 72% Increase in Health Insurance Policies Written Through RELI Exchange During 2025 Open Enrollment

Policy growth reflects strong execution and expanding distribution across RELI Exchange platform Broker network expanded from approximately 65 to approximately 300 since acquisition in 2022 LAKEWOOD, NJ, Jan. 30, 2026 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: EZRA) (the “Company”) today announced strong operating momentum across its insurance operations, highlighted by a significant year-over-year increase in health insurance policies written through its RELI Exchange, LLC subsidiary during the 2025 open enrollment period. During the 2025 open enrollment period, health insurance policies written through RELI Exchange’s Altruis Health office increased to approximately 3,873 policies, compared to approximately 2,258 policies during the 2024 open enrollment period, representing an increase of approximately 72% year over...

Continue reading

Red River Bancshares, Inc. Reports Fourth Quarter 2025 Financial Results

ALEXANDRIA, La., Jan. 30, 2026 (GLOBE NEWSWIRE) — Red River Bancshares, Inc. (the “Company”) (Nasdaq: RRBI), the holding company for Red River Bank (the “Bank”), announced today its unaudited financial results for the fourth quarter of 2025. Net income for the fourth quarter of 2025 was $11.4 million, or $1.73 per diluted common share (“EPS”), compared to $10.8 million, or $1.63 EPS, for the third quarter of 2025. For the fourth quarter of 2025, the quarterly return on assets was 1.38%, and the quarterly return on equity was 12.60%. Net income for the year ended December 31, 2025, was $42.8 million, or $6.38 EPS, compared to $34.2 million, or $4.95 EPS, for the year ended December 31, 2024. For the year ended December 31, 2025, the return on assets was 1.33%, and the return on equity was 12.58%. Fourth Quarter 2025 Performance...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.